The aims of this study were to observe the growth of vascular endothelial cells (VECs) and the vascularization of novel porcine acellular dermal matrix (PADM), and to investigate the methods for modifying heterologous dermal substitutes in order to improve their compatibility. Twenty-four Wistar rats were divided into a PADM group and a HADM group, which were transplanted with PADM and HADM, respectively. At the 3rd day, and at the 1st, 2nd, and 4th week after the operation, the dermal substitute was removed, and HE staining and CD34 and factor VIII immunohistochemical staining were performed. The distribution and proliferation of VEC, the vascularization, and histological changes in the dermal substitute were observed. At the 3rd postoperative day, tiny capillaries sprouted in the dermal substitute and began to proliferate. At the 1st postoperative week, the new capillaries extended into the dermal substitute. At the 2nd postoperative week, the new capillaries had entered the dermal substitute and further increased in number, and were more mature than the capillaries in the 1 st postoperative week (P<0.05). At the 4th postoperative week, the capillaries were distributed everywhere in the dermal substitute, along with further matured VECs, but the capillary number was not significantly increased compared with the 2nd postoperative week (P> 0.05). There was a good VEC proliferation in implanted PADM, with immigrated fibroblasts and matured capillaries. The novel PADM showed good tissue compatibility.